Yuanyuan Li | Movement Disorder | Best Researcher Award

Dr. Yuanyuan Li | Movement Disorder | Best Researcher Award

🧠 Dr. Yuanyuan Li is a dedicated neurologist and researcher specializing in neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. She obtained her Ph.D. in Neurology from Shanghai Jiao Tong University School of Medicine and has been actively involved in cutting-edge research at Ruijin Hospital’s Department of Neurology. As a project leader, she has explored the role of α-synuclein in dopaminergic neurons, investigating its transport pathways and impact on cell viability. Dr. Li has authored multiple high-impact publications in renowned journals such as Neurology and J Neuroinflammation. Her work has contributed significantly to understanding the early biomarkers of neurodegenerative disorders. She has received prestigious awards, including the National Scholarship for Doctoral Students and the Outstanding Graduate Award from Shanghai Jiao Tong University. With numerous conference presentations and accolades, Dr. Li continues to drive forward advancements in neurodegenerative disease research. ✹📚

Profile

Education 🎓

🎓 Dr. Yuanyuan Li completed her Ph.D. in Neurology at Shanghai Jiao Tong University School of Medicine, where she focused on neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. Her doctoral research emphasized the role of α-synuclein in dopaminergic neurons, uncovering its impact on neurodegeneration. Throughout her academic journey, Dr. Li consistently demonstrated excellence, earning the First-Class Academic Scholarship and the Meritorious Student Award. She was recognized as an Outstanding Graduate and received the prestigious National Scholarship for Doctoral Students. Beyond coursework, she actively engaged in translational research, bridging laboratory findings with clinical applications. Her education has provided a strong foundation in neurobiology, molecular neuroscience, and clinical neurology. With a passion for uncovering early biomarkers of neurodegeneration, Dr. Li’s educational background has shaped her into a leading researcher in the field. 📖🧬

Experience đŸ‘šâ€đŸ«

Dr. Yuanyuan Li has extensive research experience at Ruijin Hospital’s Department of Neurology, affiliated with Shanghai Jiao Tong University School of Medicine. As a principal investigator, she led the Shanghai Jiao Tong University Doctoral Innovation Fund project, studying α-synuclein’s transport mechanisms in dopaminergic neurons and its effects on cell viability. Her expertise spans biomarker discovery, neuroinflammation, and disease progression in neurodegenerative disorders. She has collaborated on numerous high-impact studies published in Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease. Dr. Li has also presented her findings at major conferences, including the National Neurology Conference and the Oriental Neurology Conference. Her experience in both basic and clinical research allows her to bridge the gap between laboratory discoveries and patient applications, advancing diagnostic and therapeutic strategies for Parkinson’s disease and related disorders. đŸ„đŸ§ 

Awards & Recognitions 🏅

Dr. Yuanyuan Li has received numerous prestigious awards for her contributions to neurology and neuroscience research. She was awarded the National Scholarship for Doctoral Students, recognizing her academic excellence and groundbreaking research. She also received the Outstanding Graduate Award and the Meritorious Student Award from Shanghai Jiao Tong University. Her outstanding academic performance earned her the First-Class Academic Scholarship, demonstrating her dedication to advancing neurological research. Dr. Li has been recognized for her contributions at major conferences, winning the “Excellent Paper Presentation” award at the Oriental Neurology Conference. Additionally, she secured First Prize for Poster Presentation at the “Bo Ji Yi Yuan” Academic Forum. Her accolades reflect her commitment to advancing our understanding of neurodegenerative diseases, particularly Parkinson’s disease. These honors highlight her as a rising star in the field of neurology. 🏅📜

Research Interests 🔬

đŸ§Ș Dr. Yuanyuan Li’s research focuses on neurodegenerative diseases, with an emphasis on Parkinson’s disease, REM sleep behavior disorder (RBD), and α-synuclein pathology. Her work explores the molecular mechanisms driving these disorders, particularly the role of α-synuclein in dopaminergic neurons, its transport pathways, and its impact on cell viability. She has also investigated immune biomarkers, neuroinflammation, and genetic variants associated with Parkinson’s progression. Dr. Li’s studies have contributed to identifying predictive markers for early-stage neurodegenerative diseases, aiding in early diagnosis and potential therapeutic interventions. Through her publications in top journals like Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease, she has advanced knowledge in the field. Her work integrates clinical and experimental neuroscience, bridging gaps between laboratory findings and real-world applications. Dr. Li’s research continues to shape the understanding of neurodegenerative disorders and their early detection. 🧬🔍

 

4Publications 
  • Gene Polymorphisms of Parkinson’s Disease Risk Locus and Idiopathic REM Sleep Behavior Disorder

    Biomedicines
    2025-03-24 | Journal article
    CONTRIBUTORS: Min Zhong; Yang Jiao; Aonan Zhao; Mengyue Niu; Jinjun Ran; Jun Liu; Yuanyuan Li
  • Understanding Causal Relationships Between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    Biomedicines
    2025-03-18 | Journal article
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.
  • Understanding Causal Relationships between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    2025-02-05 | Preprint
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.
  • Network disruption based on multi-modal EEG-MRI in α-synucleinopathies

    Frontiers in Neurology
    2024 | Journal article
    CONTRIBUTORS: Wang, Chunyi; Hu, Jiajia; Li, Puyu; Zhang, Ming; Zhou, Liche; Luo, Ningdi; Zhu, Xue; Yin, Qianyi; Zhong, Min; Zhou, Xinyi et al.

Mehmet Okur | Working Memory Intervention | Memory Mastery Award

Dr. Mehmet Okur | Working Memory Intervention | Memory Mastery Award

Dr. Mehmet Okur is a researcher and educator specializing in special education, learning disabilities, and cognitive interventions. He holds bachelor’s degrees in Mathematics and Special Education and a Ph.D. in Special Education. As the founder of the Mega-Cognition Center, he develops innovative tools to support cognitive development, attention, and learning difficulties. His research includes early screening tools for learning disabilities, ADHD interventions, and processing speed assessments. Dr. Okur has contributed significantly to special education, collaborating with experts worldwide to advance cognitive and educational research. His work bridges theory and practice, enhancing learning outcomes for individuals with diverse needs.

Profile

Education 🎓

Dr. Mehmet Okur holds dual bachelor’s degrees in Mathematics and Special Education, providing a strong foundation in both analytical and educational sciences. He earned his Ph.D. in Special Education, focusing on cognitive development, learning disabilities, and ADHD. His doctoral research contributed to the development of innovative assessment tools for early detection of learning disabilities. His academic journey includes interdisciplinary studies, integrating cognitive neuroscience with educational psychology. He continuously enhances his expertise through professional training and collaborative research, ensuring his contributions to special education remain cutting-edge and impactful.

Experience đŸ‘šâ€đŸ«

Dr. Mehmet Okur has extensive experience in special education, cognitive research, and intervention program development. As the founder of the Mega-Cognition Center, he designs educational tools for children with learning disabilities and ADHD. His work includes developing the ÖGEBTÖ screening tool, processing speed interventions, and attention assessment tests. He collaborates with institutions and researchers to enhance cognitive and learning strategies. Additionally, he has consulted on educational projects, conducted training workshops, and contributed to national and international research initiatives, making a significant impact on special education and cognitive science.

Research Interests 🔬

Dr. Mehmet Okur’s research revolves around learning disabilities, ADHD, cognitive interventions, and early screening tools. He has developed innovative assessment methods like ÖGEBTÖ for early detection of learning disabilities and interventions to improve processing speed. His work also focuses on executive function training, attention development, and working memory enhancement. He collaborates with cognitive scientists and educators to refine assessment tools and intervention strategies. His research bridges neuroscience and education, aiming to create effective solutions for children with learning challenges, ultimately enhancing their cognitive and academic performance.

Awards & Recognitions 🏅

Dr. Mehmet Okur has received recognition for his contributions to special education and cognitive research. His development of the ÖGEBTÖ screening tool earned industry and academic acclaim. He has been honored for his work in cognitive interventions, receiving nominations for prestigious awards like the Memory Mastery Award. His contributions to learning disability research, ADHD interventions, and cognitive assessment tools have been acknowledged by professional societies. His dedication to advancing educational methodologies and his commitment to improving cognitive development continue to earn him accolades in the field.

Publications 📚

Junhui Chen | Stroke | Best Researcher Award

Dr. Junhui Chen | Stroke | Best Researcher Award

Chen Junhui, MD, is an Associate Chief Physician and a postdoctoral researcher at Xiangya School of Medicine, Central South University. He has also been a visiting scholar at the University of South Florida (USF), USA. He currently serves as the lead researcher in the Neurosurgery Research Group at the 904th Hospital of the Joint Logistics Support Force. He is a member of the Vascular Group of the Neurosurgery Branch of the Jiangsu Medical Association and the Youth Committee of the Translational Medicine Professional Committee of the Chinese Microcirculation Society. He has been recognised as a “Double Hundred” outstanding young talent in Wuxi.

Profile

Education 🎓

Dr Chen holds a Doctor of Medicine (MD) from Wuhan University and completed his postdoctoral research at Xiangya School of Medicine, Central South University. He has a strong medical background and gained international research experience in neurosurgery as a visiting scholar at USF, USA.

Experience đŸ‘šâ€đŸ«

He has participated in five National Natural Science Foundation projects and led eight research projects, including those funded by the Jiangsu Provincial Natural Science Foundation and major military scientific research programmes. Dr Chen has been actively involved in both neurosurgical research and clinical treatment, specialising in endovascular intervention and microsurgical treatment of intracranial aneurysms and ischaemic stroke.

Research Interests 🔬

His research focuses on the mechanisms of neuroinjury in subarachnoid haemorrhage and the clinical and mechanistic study of delirium. Over the past five years, he has published 30 SCI papers, including 10 in top-tier journals classified as Q2 or higher in the Chinese Academy of Sciences, with his findings cited in leading journals such as Stroke.

Awards & Recognitions 🏅

Dr Chen has received numerous prestigious awards, including the Second Prize of the Hubei Provincial Science and Technology Progress Award, the Third Prize of the Military Science and Technology Progress Award, the Wuhan University Academic Innovation Award, and the Outstanding Paper Award at the World Chinese Neurosurgery Conference.

Publications 📚

Xiuwei Zhang | Psychology | Best Researcher Award

 Dr. Xiuwei Zhang | Psychology | Best Researcher Award

Xiuwei Zhang, PhD, is a researcher at Hefei University of Technology, specializing in traffic behavior and psychology. She holds a doctoral degree from Hefei University of Technology, where her work focuses on improving traffic safety through behavioral psychology methods. Zhang’s research addresses critical issues such as driver behavioral changes and children’s perception of street crossing hazards. She is deeply involved in advancing traffic safety by understanding how people interact with traffic environments, with an emphasis on psychological cognition. Zhang has also contributed significantly to the field through several published papers and patents, aiming to enhance both driver and pedestrian safety. With an established academic career and passion for traffic psychology, Zhang aims to provide actionable solutions to improve road safety globally.

Profile

Education 🎓

Xiuwei Zhang completed her undergraduate studies at Qingdao University of Science and Technology. She pursued her master’s and doctoral degrees at Hefei University of Technology, where she focused on traffic behavior and psychology. During her time at Hefei, Zhang developed a deep understanding of how psychological factors influence road safety, particularly in the context of driver behavior and children’s traffic hazard perception. Her academic training has allowed her to integrate cognitive psychology with transportation safety, paving the way for innovative solutions to reduce traffic-related accidents. Zhang’s educational background in this interdisciplinary field has made her a strong proponent of using behavioral psychology to improve urban traffic environments, with her research significantly contributing to traffic safety science.

Experience đŸ‘šâ€đŸ«

Xiuwei Zhang has experience conducting impactful research on traffic psychology at Hefei University of Technology, where she has worked on driver behavior, risk perception, and children’s safety while crossing streets. She contributed to multiple key projects, such as the optimization of urban road intersections using intelligent detection and the evolution of driver’s risk perception in co-driving vehicles. Zhang participated in developing local and national standards, such as the “Evaluation Standard for Driver Takeover Ability of Autonomous Vehicles.” Her patents include solutions for assessing and preventing conflicts between human-vehicle interactions in signal intersections. Additionally, Zhang’s academic role extends to reviewing papers for Transportation Research Part F: Traffic Psychology and Behavior. She is an active participant in cutting-edge research projects, such as the National Natural Science Foundation of China and Anhui Province’s housing and urban development projects, focusing on making roads safer through innovative traffic designs and behavioral analysis.

Research Interests 🔬

Xiuwei Zhang’s research focuses on traffic behavior and psychology, with particular attention to driver behavior, children’s traffic safety, and cognitive biases in road environments. Her work aims to enhance the perception of road hazards, particularly among children, and to improve road safety through behavioral psychology techniques. One of her significant contributions is the study of children’s perception of street-crossing risks under visually occluded conditions, providing valuable insights into how environmental factors impact traffic behavior. Zhang’s research on driver behavior changes, particularly in co-driving scenarios with automated vehicles, seeks to develop better risk perception strategies to improve safety on the roads. Her interdisciplinary approach integrates traffic safety with cognitive science, making her work influential in both the practical and theoretical aspects of traffic safety. Zhang’s innovations also extend to the design of intelligent traffic systems and road intersections, contributing to the future of urban road safety in smart cities.

Awards & Recognitions 🏅

Xiuwei Zhang has received several prestigious awards and honors during her academic career, including the “Outstanding Graduate of the School Class of 2024” and multiple scholarships, such as the School Second Class Scholarship for the 2022-2023 academic year. Her excellence as a volunteer was recognized when she was named the “Outstanding Red Cross Volunteer” of Qingdao West Coast New District in 2018. Zhang’s consistent academic achievements are highlighted by her scholarships across multiple years and her significant contributions as a member of the Auto Traffic College Institute Graduate Student Association. These accolades reflect her dedication to research, teaching, and community service. Zhang’s awards demonstrate her potential as a leader in traffic safety research and behavioral psychology, highlighting her academic excellence and contributions to improving road safety.

Publications 📚

Aynur MĂŒdĂŒroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Prof Dr. Aynur MĂŒdĂŒroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Asst. Prof. Aynur MĂŒdĂŒroğlu Kırmızıbekmez is a neuroscientist at İstanbul Nißantaßı University, specializing in neurodegenerative diseases, neuroprotection, and the gut-brain axis. She completed her Ph.D. in Neuroscience at Istanbul University in 2013 and has been a faculty member since 2014. Her research spans Alzheimer’s, autism, and Parkinson’s disease, focusing on stem cell therapies and functional foods for cognitive enhancement. She has led TÜSEB-approved projects and holds patents on bioactive functional foods. Aynur teaches Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She actively contributes to cutting-edge innovations, particularly in prebiotic-microbiota interactions.

Profile

Education 🎓

Aynur MĂŒdĂŒroğlu Kırmızıbekmez earned her Ph.D. in Neuroscience from Istanbul University in 2013. Her academic journey emphasized neurobiology, neurodegenerative disease mechanisms, and innovative therapeutic strategies. Her doctoral research focused on neuroprotective compounds in Alzheimer’s disease. Before her Ph.D., she pursued studies in molecular biology and biotechnology, refining her expertise in cellular neuroscience. Throughout her education, she collaborated on interdisciplinary projects, integrating neurophysiology with pharmacological advancements. Her postdoctoral research extended into translational neuroscience, bridging laboratory findings with clinical applications. Aynur’s academic foundation laid the groundwork for her extensive research on cognitive function, stem cell therapy, and the gut-brain axis.

Experience đŸ‘šâ€đŸ«

With over a decade of experience, Aynur MĂŒdĂŒroğlu Kırmızıbekmez has been an Assistant Professor at İstanbul Nißantaßı University since 2014. She has led multiple national and international neuroscience projects, including TÜSEB-approved research on Parkinson’s and Alzheimer’s diseases. Aynur has played a pivotal role in developing functional foods aimed at cognitive enhancement and has secured patents for novel bioactive compounds. She actively collaborates with industry and academia, integrating neuroscience with biotechnology. Her teaching portfolio includes Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She has also mentored numerous graduate students in neuropharmacology and neurodegenerative research.

Research Interests 🔬

Aynur MĂŒdĂŒroğlu Kırmızıbekmez’s research focuses on neurodegenerative diseases, neuroprotection, and the gut-brain axis. She explores innovative therapies for Alzheimer’s, Parkinson’s, and autism, with a strong emphasis on stem cell applications. Her work investigates the neuroprotective potential of bioactive compounds and functional foods, aiming to enhance cognitive function. She has pioneered research on the microbiota-brain relationship, particularly the role of prebiotics in neurodegeneration. Aynur’s projects also include SNP-based qPCR diagnostic tools for Alzheimer’s risk assessment. Through interdisciplinary collaborations, she integrates neuroscience with biotechnology, advancing the understanding of cognitive disorders and potential therapeutic interventions.

Awards & Recognitions 🏅

Aynur MĂŒdĂŒroğlu Kırmızıbekmez has received multiple awards for her contributions to neuroscience, including national research grants and innovation awards for her work on functional foods for neuroprotection. She was honored by TÜSEB for her groundbreaking research in stem cell therapy for Parkinson’s disease. Her patented functional chocolate enriched with bioactive compounds received recognition for its cognitive benefits. Aynur has also been awarded project grants from TÜBİTAK for her research on neurodegeneration. She has been invited as a keynote speaker at international neuroscience conferences and has been recognized for her contributions to cognitive science.

Publications 📚

  • Attila Altunel, Aynur Muduroglu-Kirmizibekmez, Alparslan Onder, Ozlem Altunel, Ali
    Sever, Ihsan Kara, Efficacy of ACTH therapy in children with Landau-Kleffner Syndrome
    and Autism Spectrum Disorder: A retrospective analysis, Epilepsy & Behavior,Vol
    165,2025,110308, https://doi.org/10.1016/j.yebeh.2025.11030
  • Muduroglu-Kirmizibekmez A, Cati C, Onder A, Aydin S, Kara I. Investigation of the acute
    impact of rosemary consumption on brain activity in healthy volunteers. Nutr
    Neurosci. 2024 Jul 6:1-12. doi: 10.1080/1028415X.2024.2370729. Epub ahead of print.
    PMID: 38970803.
  • Biliz Y, Hasdemir B, Baßpınar KĂŒĂ§ĂŒk H, Zaim M, ƞentĂŒrk AM, MĂŒdĂŒroğlu Kırmızıbekmez
    A, Kara İ. Novel N-Acyl Hydrazone Compounds as Promising Anticancer Agents:
    Synthesis and Molecular Docking Studies. ACS Omega. 2023 May 20;8(22):20073-
    20084. doi: 10.1021/acsomega.3c02361. PMID: 37305237; PMCID: PMC10249086.
  • Aydin S, Erözden AA, Tavßanlı N, MĂŒdĂŒroğlu A, Çalıßkan M, Kara İ. Anthocyanin
    Addition to Kefir: Metagenomic Analysis of Microbial Community Structure. Curr
    Microbiol. 2022 Sep 20;79(11):327. doi: 10.1007/s00284-022-03017-x. PMID:
    36125585
  • Altunel Atilla, MĂŒdĂŒroğlu Kirmizibekmez Aynur, Altunel Emine Özlem (2022).
    Hypsarrhythmia Paroxysm Intensities that Initiate and Render Physical & Mental
    Retardation Irreversible in West Syndrome. International Journal of Neuroscience,
    DOI: 10.1080/00207454.2022.2078208 (Publication No: 7685958)

Jeevitha Gowda R | Cognitive impairment | Best Researcher Award

Ms. Jeevitha Gowda R | Cognitive impairment | Best Researcher Award

Assistant Professor, Alliance University, United Kingdom

🧠 Dr. Jeevitha Gowda R is a dedicated research scholar specializing in cognitive neuroscience and public health, with a strong focus on dementia prevention. She has expertise in developing cognitive screening tools, conducting neuropsychological assessments, and designing neuroscience-based interventions to enhance brain health. Currently serving as a Guest Faculty and Research Associate, she is passionate about bridging research with real-world applications. With proficiency in EEG, ERP, and data analysis, her work emphasizes cognitive aging, behavioral psychology, and mental well-being. Her research contributions include multiple conference presentations, publications, and cognitive training programs. She has received prestigious recognitions, including Best Paper Awards and research fellowships. Her commitment extends to community mental health programs, where she collaborates with NGOs and research institutions. Through her work, she aims to advance cognitive neuroscience and improve public health outcomes. 📚🔬

Profile

Education 🎓

🎓 Dr. Jeevitha Gowda R holds a Ph.D. in Cognitive Neuroscience and Public Health from Ramaiah University of Applied Sciences, Bengaluru (Thesis Submitted), focusing on developing cognitive tools for early dementia detection in primary healthcare settings. She earned a Master’s in Cognitive Neuroscience from JSS Academy of Higher Education, Mysuru (2018), ranking among the top 3 students, with coursework in neural cognition, psychological assessment, and clinical interventions. Her dissertation explored mental fatigue due to sleep deprivation using EEG and ERP. She completed her Bachelor’s in Life Sciences from JSS College for Women, Mysuru (2016), excelling in biochemistry, microbiology, and environmental psychology. Additionally, she trained at the Defence Institute of Psychological Studies (DRDO) and Narayana Health, Bengaluru, gaining hands-on experience in EEG, neuropsychological assessments, and cognitive therapy. Her interdisciplinary education combines neuroscience, psychology, and public health, preparing her for impactful research and innovation in brain health. 🧠📖

Experience đŸ‘šâ€đŸ«

đŸ’Œ Dr. Jeevitha Gowda R has extensive experience as a Research Associate at the Centre for Integrative Health and Well-Being (2020–Present), where she develops neuropsychological intervention tools and conducts cognitive behavioral therapy (CBT) programs. She also serves as a Senior Research Associate at Brighter Minds, focusing on cognitive enhancement and neuroscience-based training programs. As a Guest Lecturer at Ramaiah University of Applied Sciences (2021–Present), she teaches biostatistics, neurophysiology, and psychology. Her past clinical internships at DRDO and Narayana Health provided her with hands-on expertise in EEG, ERP, and neuropsychological assessments. She has conducted research on cognitive impairment, dementia screening, and sleep deprivation’s effects on cognition. Additionally, she has authored 50+ neuroscience articles, presented at international conferences, and collaborated with NGOs for mental health awareness. Her diverse experience integrates academic, clinical, and research-based expertise to advance cognitive neuroscience and public health. đŸ„đŸ“Š

Research Interests 🔬

🔬 Dr. Jeevitha Gowda R’s research bridges cognitive neuroscience, psychology, and public health, focusing on early dementia detection, cognitive aging, and neuropsychological interventions. She specializes in developing culturally relevant cognitive screening tools for primary healthcare, improving accessibility to dementia diagnostics. Her work explores neuropsychological assessments, EEG-based cognitive analysis, and behavioral interventions for enhancing mental well-being. She has conducted studies on sleep deprivation, cognitive impairment, and neurofeedback therapy. She collaborates with institutions like DRDO, Narayana Health, and Brighter Minds to implement neuroscience-driven programs. Her research extends to the psychological well-being of dementia caregivers, neurocognitive training for brain health, and integrating technology into mental health solutions. Through interdisciplinary studies and global research collaborations, she aims to advance early dementia detection methods and improve cognitive health strategies. Her work contributes to policy-making, clinical psychology, and public health initiatives. đŸ„đŸ“Š

Awards & Recognitions 🏅

🏆 Dr. Jeevitha Gowda R has received multiple accolades for her contributions to cognitive neuroscience and public health research. She won the Best Paper Award at the Epidemiology Foundation of India Conference (2023, Goa) for her groundbreaking work on dementia screening. Her research paper on cognitive tool validation earned a Special Mention at the International Dementia Conference (DEMCON-2024, IISC Bangalore). During her master’s, she ranked among the top 3 dissertations at JSS Academy of Higher Education. She was awarded the Senior Research Fellowship (SRF) by Ramaiah University of Applied Sciences (2022–2024) for her Ph.D. research. She has also secured research grants for projects on dementia detection and cognitive enhancement. Recognized for her impactful contributions, she collaborates with prestigious institutions, including DRDO and Narayana Health, to advance neuropsychological research. Her work continues to shape innovations in mental health and aging. đŸŽ–ïžđŸ§ 

Publications 📚

  • Jeevitha Gowda R, Anish Mehta, Krishnamurthy Jayanna. (2025).
    Dementia: A Public Health Challenge in India. South Eastern European
    Journal of Public Health, 29–43. Retrieved from
    hps://www.seejph.com/index.php/seejph/article/view/3295 (Scopus)

  • Jeevitha Gowda R. The Impact of Cultural Beliefs and Stigma on
    Dementia Care and Diagnosis: A Scoping Review, 25 November 2024,
    PREPRINT (Version 1) available at Research Square
    hps://doi.org/10.21203/rs.3.rs-5519592/v1
  • Jeevitha Ramesh, Parimala Guruprasad (2024) Factors Affecting the
    Psychological Well-Being of Caregivers of Dementia Patients: A
    Thematic Review. Journal of Neurology Research Reviews & Reports.
    SRC/JNRRR-260
  • Development and Validation of Cognitive Screening Tools for
    Dementia Detection in Primary Care Seings: An Exploratory Pilot
    Study – Under review at International Journal of Geriatric Psychiatry.
    (Corresponding Author)
  • Burden of Cognitive Impairment Including Dementia, and Associated
    Risk Factors Among the Rural Population of South Karnataka, India –
    Under review at Journal of Public Health Research. (Corresponding
    Author)
  • Impact of Training Module on Lifestyle and Healthy Behaviours: An
    Exploratory Pilot in India – Under review at Journal Explore.
    (Co-Author)

Carmela Conte | Neurodegenerative diseases | Best Researcher Award

Prof Dr. Carmela Conte | Neurodegenerative diseases | Best Researcher Award

 

Profile

Education

Carmela Conte obtained her Master’s degree in Biological Sciences from the University of Perugia on November 3, 1994. She then pursued a Ph.D. in Medical Embryology through a joint program between the Universities of Perugia and Ferrara, completing it between December 30, 1996, and January 19, 2000. Following this, she specialized in Chemistry and Food Technology at the University of Perugia, earning her specialization between November 1, 2000, and November 1, 2002. Most recently, on September 29, 2023, she received National Habilitation as an Associate Professor in Biochemistry. She currently serves as an Aggregate Professor in her field.

Work experience

Since September 7, 2007, Carmela Conte has been serving as an Aggregate Professor in Biochemistry at the University of Perugia, where she teaches courses in General and Systematic Biochemistry, Medical Applied Biochemistry, and Molecular Biology. In addition to her teaching responsibilities, she participated in a Teaching and Training Mobility Program at VUMC Medical University of Amsterdam from June 24 to July 5, 2019, where she worked on a research project investigating the role of Toll-like receptors in Parkinson’s disease. She has been a member of the European Society for Neurochemistry since 2007 and, since March 17, 2022, has also been affiliated with the International Parkinson and Movement Disorder Society.

Research Activity

Carmela Conte’s research focuses on neurodegenerative diseases, with particular emphasis on animal models, signal transduction, molecular biology, and cell biology. Her specific research topics include the role of Toll-like receptors in Parkinson’s disease, neuroinflammation, synucleinopathies, oxidative stress, and Parkinson’s disease. Since September 7, 2007, she has been actively involved in editorial work, serving as a Reviewer Editor for Frontiers in Neuroscience (Neurodegeneration section) and as an ad hoc reviewer for several journals, including Amino Acids, The Cerebellum, Free Radical Research, Biomolecules, PLOS One, Experimental Gerontology, Molecules, Cells, Neurochemical Research, Neuroscience, Pharmacological Reports, International Journal of Molecular Sciences, Viruses, and the Journal of Biotechnology. Additionally, she has been a Guest Editor for Molecules and Cells, overseeing special issues and topic collections on neurodegenerative diseases. She has presented her research at numerous scientific meetings and conferences, including the 2009 Meeting of the European Society for Neurochemistry in Leipzig, the 2019 European Biotechnology Congress in Valencia, the 2021 European Biotechnology Congress in Sofia, the 2022 National Meeting of the Sphingolipid Club, and the 2023 Meeting of Parkinson’s Disease and Movement Disorders, where she discussed findings related to Toll-like receptor 4, alpha-synuclein accumulation, and sphingomyelinase activity in Parkinson’s disease models.

Publication

Nuray Alaca | Motor İmagery | Best Researcher Award

Prof Dr. Nuray Alaca | Motor İmagery | Best Researcher Award

 

Profile

Education

She completed her Doctorate in Physiology at Marmara University, Institute of Health Sciences, Turkey, from 2011 to 2015. Prior to that, she earned her Postgraduate degree in Orthopedic Rehabilitation from the same institute between 1999 and 2002. Her academic journey began with an Undergraduate degree in Physiotherapy and Rehabilitation from Istanbul University, School of Physical Therapy and Rehabilitation, where she studied from 1995 to 1999.

Research 

Her research focuses on physiotherapy and rehabilitation, with a strong academic background in the field. She has been serving as an Associate Professor at Acibadem Mehmet Ali Aydinlar University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, since 2021. Prior to this, she worked as an Assistant Professor from 2016 to 2021 and as a Lecturer from 2011 to 2015 at the same institution.

She has been actively involved in various research projects in physiotherapy and rehabilitation, supervising both postgraduate and doctoral students. Her ongoing research includes a randomized controlled trial on graded motor imagery as an adjunct to physiotherapy in chronic rotator cuff-related pain and an investigation into the sensorimotor representation of body schema in adolescent idiopathic scoliosis compared to healthy individuals. In 2024, she supervised a postgraduate study on the effect of manual lymph drainage in treating breast edema in patients undergoing breast-conserving surgery and adjuvant radiotherapy. Additionally, she is leading a doctoral study examining the effects of tactile stimulation, swimming exercise, or their combination on oxidative stress, inflammation, amyloid beta, neurogenesis, neurotrophic factors, and molecular signaling in an Alzheimer’s model. Her recent research includes a 2023 retrospective study on the effects of tumor type and treatments on lymphedema levels in breast cancer patients undergoing complex decongestive lymphedema therapy. She also supervised a 2021 postgraduate study exploring the effects of swimming exercise, low-level laser, or their combination on degeneration, inflammation, oxidative stress, utrophin protein, and irisin peptide in Duchenne muscular dystrophy (MDX) mice.

Publication

  • Comparison of Pressure Feedback Biofeedback Training with Conventional Lumbar Dynamic Strength Exercises for Chronic Low Back Pain: A Prospective Randomized Trial.

    Alternative therapies in health and medicine
    2024-11-18 | Journal article
    PMID: 39565706
    CONTRIBUTORS: ÖztĂŒrk Ü; Çörekçi AA; Alaca N; Subaßı F
  • Comparison of static balance and pressure distribution in individuals with unilateral lower limb amputation: The role of barefoot, heel support, and vision.

    Prosthetics and orthotics international
    2024-11-08 | Journal article | Author
    PMID: 39514704
    CONTRIBUTORS: Tatar Y; NilĂŒfer Kablan; Nejla Gercek; Nuray Alaca
  • Kinesiophobia, physical activity levels and barriers in breast cancer patients, survivors, and healthy controls: A case-control analysis.

    JPMA. The Journal of the Pakistan Medical Association
    2024-08-01 | Journal article
    PMID: 39160708
    CONTRIBUTORS: Alaca N; Karayazi KT; Arslan DC; Karakus MB; Uras C
  • The immediate effect of thoracolumbar fascia taping on biomechanical properties, low back pain and balance in individuals with transfemoral amputation.

    Journal of back and musculoskeletal rehabilitation
    2024-01 | Journal article
    PMID: 38517772
    CONTRIBUTORS: Çalıßkan Z; Alaca N; Kablan N

Crhistiane Andressa da Silva | Chronobiology and Memory | Neurocognitive Breakthrough Award

Dr. Crhistiane Andressa da Silva | Chronobiology and Memory | Neurocognitive Breakthrough Award

 

EstĂșdio Amanhecer, Brazil

Profile

Education

She earned her Doctorate in Psychology from the Universidade Federal do Rio Grande do Norte (UFRN), Natal, Brazil, in 2012, with a Sandwich Doctorate at the Universitat de Barcelona under the supervision of Antoni Díez-Noguera. Her doctoral research, titled SAGUIS (Callithrix jacchus) SOB CICLO CLARO-ESCURO DE 21 H: UM MODELO DE DESSINCRONIZAÇÃO FORÇADA EM PRIMATA DIURNO, was conducted under the guidance of John Fontenele Araujo, with Carolina Virgínia Macedo de Azevedo as a co-advisor. She received a scholarship from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.

She completed her Master’s in Pharmacology at UFRN in 2007, with a thesis titled EFEITOS DE VOCALIZAÇÕES DE CO-ESPECÍFICOS E DO ESCURO SOBRE O RITMO CIRCADIANO DA ATIVIDADE MOTORA EM SAGÜIS (Callithrix jacchus), under the supervision of Carolina VirgĂ­nia MacĂȘdo de Azevedo. Her research was supported by a CAPES scholarship.

She earned her Bachelor’s degree in Biological Sciences from UFRN in 2003, with a thesis titled Perfil DiĂĄrio do Comportamento de Autocatação Durante Um Ciclo Ovariano em DĂ­ades de Saguis (Callithrix jacchus), under the supervision of Carolina VirgĂ­nia MacĂȘdo de Azevedo. She received a scholarship from the Conselho Nacional de Desenvolvimento CientĂ­fico e TecnolĂłgico (CNPq), Brazil.

Work experience

She worked as a Postdoctoral Researcher at the Universidade Federal da ParaĂ­ba (UFPB) from 2014 to 2017 under a full-time and exclusive contract. She then continued her postdoctoral research at the Universidade Federal de Pernambuco (UFPE) from 2017 to 2018 under the same work scheme.

In 2018, she served as a part-time Professor at Faculdade Escritor Osman da Costa Lins (FACOL), where she taught the course PrĂĄticas Integrativas Complementares em SaĂșde for the Physiotherapy program.

Since 2021, she has been the owner and full-time instructor at EstĂșdio Amanhecer, where she teaches yoga.

Areas of Expertise

She specializes in Public Health within the broader field of Health Sciences, as well as Physiology and General Biology within Biological Sciences. Her expertise also extends to Zoology, with a focus on Animal Behavior.

Scientific, Technological & Academic Production

She has contributed to bibliographic research and publications in her fields of study.

Citations

Her research has been cited in various academic databases:

  • Web of Science: 44 citations across 3 articles (as of June 2, 2024), with an H-index of 3.
  • Google Scholar: 26 citations across 9 articles (as of January 17, 2017).

The citation search included variations of her name: Silva, C.A.; da Silva, C.A.; CA da Silva; CA Silva; C da Silva, Crhistiane Andressa da Silva; Christiane Andressa da Silva; da Silva, Christiane Andressa; da Silva, Crhistiane Andressa

Awards & Recognitions

  • 2023 & 2024: TOP MASTER GOLD award by popular vote, recognized as a distinguished professional in her field in Rio Grande do Norte for her contributions to local development.
  • 2022: Named Best Yoga Teacher of 2022 in Natal and awarded Best of the Year in Natal.
  • 2017: Secured second place in the Banner category on the theme Chronobiology at the IX Symposium of Psychobiology.

Publication

Marcelo Luis Berthier | Neuroscience| Best Researcher Award

Prof. Marcelo Luis Berthier | Neuroscience| Best Researcher Award

 

Unversidad de MĂĄlaga, Spain

Profile

Education

Marcelo Luis Berthier obtained his degree in Medicine (1972-1976) and completed residency training in Neurosurgery (1977-1980), later specializing in Neurology (1980). He served as a staff neurologist at the Institute of Neurological Research, FLENI, Buenos Aires, Argentina (1980-1989), before becoming a research fellow in the Department of Neurology at Clinic Hospital of Barcelona, Spain (1989-1990). From 1991 to 2000, he was a staff neurologist and physician in charge of the Behavioural Neurology Unit at the Clinic University Hospital of Malaga. He earned a PhD in Neuroscience (cum laude) from the University of Malaga and coordinated the Group of Behavioural Neurology and Dementia of the Spanish Neurological Society (2004-2006). In 2004, he founded and directed the Unit of Cognitive Neurology and Aphasia at the Centro de Investigaciones MĂ©dico-Sanitarias, University of Malaga, leading it until 2023. Additionally, he served as the director of the Consolidated Research Group on Cognitive Neuroscience: Aphasia and Related Disorders (UNCA, C-12) at the Instituto de InvestigaciĂłn BiomĂ©dica de MĂĄlaga (IBIMA – Plataforma BIONAND).

Work experience

Dr. Marcelo L. Berthier Torres has led and contributed to several groundbreaking research projects in cognitive neurology and aphasia. As a co-investigator, he participated in the Telerehabilitation in Aphasia project (2021-2023), which evaluated the effectiveness of telerehabilitation compared to face-to-face therapy and identified predictive biomarkers of response, funded by the Junta de AndalucĂ­a. He also served as the principal investigator for a study on the efficacy of combined treatment with donepezil, intensive rehabilitation, and transcranial direct current stimulation in chronic post-stroke aphasia (2016-2019), funded by the Instituto de Salud Carlos III. Additionally, he has contributed to the Proyectos de GeneraciĂłn de Conocimiento “Frontera”, an initiative under the FEDER AndalucĂ­a 2014-2020 program, which investigates brain biomarkers for individualized treatment approaches in chronic post-stroke aphasia

Areas of Research

Dr. Marcelo L. Berthier Torres has made significant contributions to the treatment of post-stroke aphasia and speech-language disorders. He conducted the first open-label and randomized, placebo-controlled, double-blind trials investigating the use of cognitive-enhancing drugs (donepezil and memantine) alone and in combination with standard aphasia therapy or intensive language-action therapy (ILAT) in chronic post-stroke aphasia. His pioneering studies stimulated international research on aphasia pharmacotherapy, leading to clinical translation. Today, donepezil and memantine, alone or combined with therapy, are widely used off-label for post-stroke aphasia and language disturbances associated with neurodegenerative disorders like Alzheimer’s disease and primary progressive aphasia.

Publication

  • Revisiting the boundaries of different altered accents profiles

    Cortex
    2025-03 | Journal article
    CONTRIBUTORS: Marcelo L. Berthier; Ignacio Moreno-Torres; Jo Verhoeven; Guadalupe Dåvila
  • Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System

    CNS Drugs
    2023-07 | Journal article
    CONTRIBUTORS: Guadalupe Dåvila; María José Torres-Prioris; Diana López-Barroso; Marcelo L. Berthier
  • Pharmacotherapy for post-stroke aphasia: what are the options?

    Expert Opinion on Pharmacotherapy
    2023-07-24 | Journal article
    CONTRIBUTORS: Marcelo L. Berthier; Guadalupe Dåvila
  • Brain structural and functional correlates of the heterogenous progression of mixed transcortical aphasia

    Brain Structure and Function
    2023-05-31 | Journal article
    CONTRIBUTORS: Diana López-Barroso; José Paredes-Pacheco; María José Torres-Prioris; Guadalupe Dåvila; Marcelo L. Berthier
  • Controlling the past, owning the present, and future: cholinergic modulation decreases semantic perseverations in a person with post-stroke aphasia

    Aphasiology
    2022-11-02 | Journal article
    CONTRIBUTORS: Marcelo L. Berthier; Daniel Santana-Moreno; Álvaro Beltrån-Corbellini; Juan C. Criado-Álamo; Lisa Edelkraut; Diana López-Barroso; Guadalupe Dåvila; María José Torres-Prioris